Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer

Clinical trial NCT04330040 · COMPLETED

Trial details

NCT number: NCT04330040
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ovarian Cancer Breast Cancer

Start date: 2020-05-25
Primary completion: 2022-09-30
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.